U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470125) titled 'Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers' on March 10.
Brief Summary: A randomized, open-label, single-dose, 2-sequence, 2-period, crossover clinical trial to investigate the bioequivalence between YHP2511 and YHP2511A in healthy volunteers
Study Start Date: June 23, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Subjects
Intervention:
DRUG: YHP2511
Test drug: YHP2511, Comparator: YHP2511A
DRUG: YHP2511A
Test drug: YHP2511, Comparator: YHP2511A
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Yuhan Corporation
Disclaimer: Curated by HT Syndication....